Zimmer Biomet Launches You'll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger
Schwarzenegger Invites People Living with Joint Pain to Join New Online Community, Share Their Stories and Connect with a Qualified Physician
WARSAW, Ind., Feb. 26, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the launch of the You'll Be Back campaign with the Company's Chief Movement Officer, Arnold Schwarzenegger. The goal of the You'll Be Back campaign is to provide the millions of people living with joint pain an online community that empowers them with resources to make informed choices about their mobility. People living with limited mobility due to hip, knee, shoulder or other joint pain, are invited to share their story with Schwarzenegger as part of this launch.
Experience the full interactive Multichannel News Release here: https://www.multivu.com/zimmer-biomet/9309351-en-zimmer-biomet-arnold-schwarzenegger-youll-be-back-campaign
"Throughout my decades-long fitness crusade, I have seen the power in building community. You'll Be Back aims to bring together people who are struggling with their mobility and inspire change and action," shared Schwarzenegger, Chief Movement Officer at Zimmer Biomet, global wellness icon and founder of the daily newsletter, "Arnold's Pump Club." "People want to be successful, but fear, uncertainty and lack of vision can get in their way. Whether you want to play on the floor with your grandkids like I do, get up out of the chair pain-free or train for your next 5K race, life is too short to let pain stop you from doing what you love! I want to hear from you what is holding you back."
"There are millions of people living in pain and very few are doing anything about it and instead living in pain for years before seeking treatment," said Ivan Tornos, President and Chief Executive Officer of Zimmer Biomet. "No one is better positioned to ignite this movement to motivate people to terminate their pain more than the Terminator himself. The rapid innovation we are driving in our industry has made it easier and faster to recover from joint replacement surgeries. Now is the time to empower patients to have a voice and a choice in their health journey."
Beginning today, people living with joint pain or limited mobility can submit stories about their experience on www.YoullBeBack.com. Schwarzenegger and his team will read the submissions and select community members to be featured in a motivational docuseries.
Osteoarthritis, the most common reason for joint replacement, occurs when the cartilage that cushions and protects the ends of your bones gradually wears away, leading to progressive pain and stiffness that makes it difficult to do everyday activities. The Centers for Disease Control estimates nearly 27 million Americans over the age of 65 are impacted by the condition.1 Joint replacement, a surgical procedure where a damaged joint or part of a joint is replaced with an implant, may be recommended by a physician when other treatments are not effective in relieving pain.2 By 2030, an estimated 4 million people in the U.S. will be in need of a joint replacement.3
Visit www.YoullBeBack.com to share your story, join the community, subscribe for updates, and access the "Find a Doctor" tool to find a qualified physician near you.
About Arnold SchwarzeneggerArnold Schwarzenegger is a global icon known for his many accomplishments ranging from world-champion bodybuilder, Hollywood action hero, businessman, environmentalist, philanthropist, best-selling author and public servant. Known for his roles in blockbuster films and as Governor of California from 2003-2011, he most recently has joined Zimmer Biomet as Chief Movement Officer. Follow Schwarzenegger on LinkedIn, Instagram, Facebook and X / Twitter.
About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.ZimmerBiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.
MediaInvestors
Heather Zoumas-Lubeski445-248-0577heather.zoumaslubeski@zimmerbiomet.comDavid DeMartino646-531-6115david.demartino@zimmerbiomet.com
Kirsten Fallon781-779-5561kirsten.fallon@zimmerbiomet.comZach Weiner908-591-6955zach.weiner@zimmerbiomet.com
Sources:
https://www.thereadypatient.com/knee/6-things-you-may-not-know-about-osteoarthritis.html
https://www.niams.nih.gov/community-outreach-initiative/understanding-joint-health/joint-replacement-surgery#:~:text=Arthritis%20or%20simply%20years%20of,%2C%20grow%2C%20and%20repair%20themselves.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5485224/#:~:text=Total%20joint%20arthroplasty%20(TJA)%20is,million%20by%202030%20%5B3%5D
View original content:https://www.prnewswire.com/news-releases/zimmer-biomet-launches-youll-be-back-campaign-with-chief-movement-officer-arnold-schwarzenegger-302385394.html
SOURCE Zimmer Biomet Holdings, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Letters: He overdosed after being turned away by S.F. drug treatment center. Mother seeks answers
Jonathan Martin, my son, overdosed after he was turned away from HealthRight360's detox facility on Aug. 27, 2024. Jonathan was desperately ill and seeking help. He died alone early the next morning. Jonathan's death was the subject of a Chronicle story ('He overdosed waiting for help. Why did S.F.'s largest drug treatment center provider turn him away?' San Francisco, Feb. 27). When the story was published, I sent a letter to Mayor Daniel Lurie, District Attorney Brooke Jenkins, the chiefs of the Department of Public Health and relevant agencies, HealthRight360 CEO Vitka Eisen and every member of the Board of Supervisors, hoping to find out why my son was turned away. I wanted to understand what prevented him from receiving the services he so urgently needed. I have still not received a single response, explanation or even a note of condolence from any of these officials. If the people who oversee drug treatment in the city will not answer a grieving mother, who will give my family answers? Citizens of San Francisco: You voted these people into office. Is this how you want your loved one to be treated while trying to seek help? The silence from those in power is deafening. Our family demands answers. Carolyn Stueve-Martin, Tulsa, Okla. Don't hide Pride I empathize with her desire for concealment, misdirection or camouflage during a time of danger. My wife is trans, and this is a scary time for us. But I am afraid that Judd is missing the purpose of Pride entirely. Pride is not about shame. It's not about showing off our most socially acceptable community members in the hopes that bigots will leave the rest alone. It is the bigots who should be ashamed. A Pride celebration that is ashamed of its trans and genderqueer members — who are, as Judd wrote, just people trying to live their lives openly and freely — is no Pride at all. Amanda Seyfer, Oakland Big Brother rising Technology has always been a double-edged sword. Fire can provide warmth and light, but it can also be used to burn down an enemy village. IBM's punch cards helped make Social Security possible, but also enabled Hitler's destruction of European Jewry. Today, a shadowy Bay Area company called Palantir is coalescing federal government information on Americans into a database that would allow it to target anyone who dissents from its autocratic policies or has characteristics that it does not favor. We need our representatives (or the courts) to block this monstrous machine before it rolls over us and makes this country a new Reich just like the old Reich.
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
New Alzheimer's blood tests make diagnosis easier — but they're not right for everyone
The number of Americans with Alzheimer's disease, the most common cause of dementia in the U.S., is projected to rise significantly in the coming decades. The devastating disease has no cure, but the past several years have brought promising developments in new drug therapies and blood tests that help doctors treat and diagnose the disease. Here's what to know about the blood tests that diagnose Alzheimer's, one of which got full FDA approval in May. How they work Several commercially available blood tests have become available the past few years, most recently from biotech company Fujirebio Diagnostics, which got full approval from the FDA last month. Each test measures slightly different things, but overall they look for abnormal levels of certain proteins — amyloid and tau — in the blood. The accumulation of amyloid and tau proteins in the brain, often called plaques, are hallmark signs of Alzheimer's. If someone has tau plaques in the brain, for instance, some of that will leak out of the brain into the blood, resulting in a blood test result showing higher than normal levels of tau. In patients with symptoms of cognitive impairment, the tests predict an Alzheimer's diagnosis with about 90% accuracy. Why they're important The blood tests are a notable development because they are less expensive and less invasive than other types of testing that doctors have long used to diagnose patients with Alzheimer's. One is a PET scan, which involves injecting a patient with a radioactive tracer that binds to amyloid or tau in the brain so the presence of the proteins can be seen in a scan. It can cost several thousand dollars, compared to several hundred dollars for a blood test. The other is a spinal tap, which is painful or uncomfortable for many people. This method measures different forms of amyloid and tau in the spinal fluid. 'Up until these blood tests came out, a physician was stuck doing a PET scan or spinal tap, so not great options,' said Dr. Frank Longo, a professor of neurology at Stanford Medicine. 'The big breakthrough is finding something to measure in the blood that's about 90% accurate of what's going on in the brain, about as accurate as spinal fluid or a PET scan.' Doctors use the blood test as part of a broader medical evaluation that also includes a patient history, neurological exam and other testing. The blood test can help rule out Alzheimer's as the cause of a patient's cognitive impairment and potentially avoid unnecessary further testing. If someone's blood test comes back normal, for example, they may not have to undergo the PET scan or spinal tap, and their doctor can look into other potential causes of the cognitive impairment. 'That's the biggest practical thing it's doing now,' Longo said. It's important to distinguish Alzheimer's from other types of dementia because there are Alzheimer's treatments that have come out the last few years that help slow the progression of Alzheimer's. But patients must be in relatively early stages of the disease, with mild impairment or mild dementia, to be eligible. Some of the therapies have significant side effects, so patients would not want to start them unless they knew it was Alzheimer's, and not something else, causing the dementia. They're not for everyone The tests are approved only for people who already have symptoms of cognitive impairment and are of a certain age — 55 and over or 60 and over, depending on the test. They are not approved for healthy adults with normal cognition who want to diagnose or rule out Alzheimer's, or who are simply curious if they are at risk for developing Alzheimer's. They must be ordered by a doctor. They're becoming more common, but may not be covered by insurance Some of the blood tests have been available for a year or two, Longo said, but they were under an earlier and more limited type of FDA approval, not the full approval that the agency granted last month to the Fujirebio test. So they are poised to become more common. 'A year ago, most of my colleagues and I were not ordering these,' Longo said. 'I'd say less than 5% or 10% of the time we were ordering these. Now people are starting to order them in symptomatic patients. It's not rare now. They're starting to be recognized more.' Some primary care doctors are starting to order the tests as well, said Dr. Armen Moughamian, medical director of Sutter Health's Ray Dolby Brain Center at CPMC in San Francisco. The center treats patients with memory disorders. 'It's definitely a minority, but I've been seeing it done,' he said. As with many new medical tests, insurers may not cover them yet, but that usually evolves over time. Full FDA approval may help make the case for the tests to be covered, Longo said. 'There is some uncertainty and lack of clarity about whether insurance and Medicare pay,' Moughamian said. 'That creates some hesitancy for providers to order it.' They may one day be used to screen and diagnose healthy people earlier In people with Alzheimer's, amyloid plaques begin to form in the brain as many as 20 years before they show symptoms. Right now, newer therapies for Alzheimer's — like lecanemab and donanemab, which slow the progression of the disease — are approved only for people with symptoms. Those symptoms are mild cognitive impairment or mild dementia, the early stages of symptomatic Alzheimer's. This means people who have not yet developed symptoms, but who have amyloid plaques in the brain, cannot get these treatments. So if a blood test could be used in pre-symptomatic people, it could mean better screening and earlier diagnosis to larger groups of people. 'What we want to push for is earlier diagnosis because new therapies are available when we catch people in earlier stages,' Moughamian said. Moughamian is leading two clinical trials that examine whether drugs that remove amyloid in the brain, donanemab and another drug remternetug, can work in people who have amyloid plaques but have not yet developed symptoms. They are using an Alzheimer's blood test to see whether patients are eligible for the trial.
Yahoo
3 hours ago
- Yahoo
Yes, biking can be a lot of fun. But is it good exercise?
Few summer activities are as popular as cycling. Whether you're going for a leisurely ride along a city bike trail, hopping on a mountain bike to practice stunts and explore nature or using your bicycle as a mode of transportation to and from the store or work, you're sure to spot other cyclists nearby. In fact, cycling is the third most popular recreational activity in the U.S. with more than 56 million Americans doing it in 2024 alone. But beyond being a lot of fun and good for one's mental health by improving social connections and spending time outside, is cycling actually good exercise? Here's how biking can be good for both your heart and your muscles, plus how to get the most out of a cycling workout. Biking – or cycling, as it is more commonly called – "is considered an excellent form of exercise due to its numerous health benefits," says Dr. Michael Fredericson, director of the physical medicine and rehabilitation division of Stanford University. As a moderate-intensity aerobic exercise, it boosts cardiovascular health by elevating your heart rate, lowering your blood pressure, strengthening cardiac tissue, improving respiratory fitness and reducing your risk of heart disease. "It's also helpful in stabilizing blood glucose levels, lessening insulin resistance and lowering cholesterol by improving blood lipids," says Daryl Parker, emeritus professor of exercise science at Sacramento State University. Such benefits are among the reasons research shows "a strong relationship between commuter cycling and decreased all-cause mortality," says Fredericson. Cycling also builds endurance, releases feel-good hormones and improves flexibility and joint mobility. And the activity burns plenty of calories, with research from Harvard Medical School showing a 155-pound person burning 252 calories in just 30 minutes of moderate intensity cycling and close to 300 calories when doing so vigorously. The exercise also "enhances metabolic function," says Brad Schoenfeld, a professor of exercise science at Lehman College of the City University of New York, which means it's using more energy that other movements, leading to burning more fat stores for energy. This is why studies show that cycling can be helpful in preventing obesity and maintaining a healthy is aerobic exercise? And what are some examples? Along with such cardiovascular and weight management benefits, regularly riding your bike can also help you build muscle. While cycling involves muscle groups throughout most of the body, most growth occurs in the lower body and hip flexor muscles. "The quadriceps muscle group is particularly heavily engaged during pedaling," says Fredericson, "and the hamstrings are also activated." He points out that hip flexors are involved to aid with balance and stabilization and glute muscles are also strengthened. "And it's fair to say that upper body muscles such as the trapezius, latissimus dorsi and anterior deltoid are also engaged," he adds. Cycling accomplishes such growth through the force of resistance that propelling one's weight forward, but it also releases "chemicals known as metabolic stimuli in the muscle that can lead to an increase in muscle size," says Parker. What's more, the activity has the advantage of aiding in muscle growth and maintenance while still being a low-impact exercise – meaning it's unlikely to aggravate your bones and joints. At the same time, you're only likely to keep building muscle to a certain point before most of your time on a bike will be spent maintaining the muscles you already have. Because you're not able to keep adding more and more weight to the exercise, "cycling does not progressively overload your muscles," Schoenfeld says. "For continued increases in muscle size, a person would need to perform resistance training." Resistance vs. strength training? Learn how to build strength and muscle mass Capitalizing on the cardiovascular and muscle-building benefits of cycling means participating in the sport regularly. The U.S. Centers for Disease Control and Prevention recommends adults get at least 150 minutes of moderate-intensity physical activity per week. Cycling is one of many exercises that qualify, but meeting this recommendation means doing it or other similar activities for at least 30 minutes a day, 5 days a week. No matter how often you engage in cycling, it's important to do so safely. "To stay safe while bike riding, wear a helmet, be visible with bright clothing and lights, follow traffic laws, use hand signals and be aware of your surroundings," advises Fredericson. He also recommends inspecting your tires, brakes and other components often to ensure they are in good working order and making sure your bike frame is the correct size for your body. Parker agrees, noting that local bike shops can be helpful with fitting you to the best size of bicycle. "And don't neglect learning how to handle your bicycle effectively," he adds. "The knowledge of how to stop quickly and dismount and how to make quick turns to avoid obstacles, other riders and automobiles are all important skills in staying safe." This article originally appeared on USA TODAY: Is biking good exercise? It's better for you than you might think.
